Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Items 101–200 of 783
Audoly, L. P., Rocca, B., Fabre, J.-E., Koller, B. H., Thomas, D., Loeb, A. L., Coffman, T. M., & FitzGerald, G. A. (2000) · Circulation · doi:10.1161/01.cir.101.24.2833 · Cited by 193
Distribution and function of prostanoid receptors: studies from knockout mice
Sugimoto, Y., Narumiya, S., & Ichikawa, A. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00008-4 · Cited by 193
Self-citationStalker, T. J., Newman, D. K., Ma, P., Wannemacher, K. M., & Brass, L. F. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-29423-5_3 · Cited by 167
“Conversely, loss of PGI2 receptor (IP) expression causes a decrease in basal cAMP levels, enhances responses to agonists and predisposes mice to thrombosis in arterial injury models (Murata et al. 1997; Yang et al. 2002).”
BackgroundOga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2066 · Cited by 190
Self-citationPatrono, C., Coller, B., Dalen, J. E., Fuster, V., Gent, M., Harker, L. A., Hirsh, J., & Roth, G. (1998) · Chest · doi:10.1378/chest.114.5_supplement.470s · Cited by 190
Ailhaud, G., & Guesnet, P. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00121.x · Cited by 189
“In contrast, IP-deficient mice (33) fed either diet are similar in this respect, indicating that the prostacyclin signalling contributes significantly to adipose tissue development.”
BackgroundFunction of prostanoid receptors: studies on knockout mice
Kobayashi, T., & Narumiya, S. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00055-2 · Cited by 185
Self-citationPark, G. Y., & Christman, J. W. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00513.2005 · Cited by 182
Murine Models of Vascular Thrombosis
Westrick, R. J., Winn, M. E., & Eitzman, D. T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.142810 · Cited by 184
Cytochrome P450 enzymes: Central players in cardiovascular health and disease
Elbekai, R. H., & El-Kadi, A. O. S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.011 · Cited by 181
Gross, S., Tilly, P., Hentsch, D., Vonesch, J.-L., & Fabre, J.-E. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061617 · Cited by 180
Minami, T., Nakano, H., Kobayashi, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Ito, S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704092 · Cited by 180
Self-citationClaveau, D., Sirinyan, M., Guay, J., Gordon, R., Chan, C.-C., Bureau, Y., Riendeau, D., & Mancini, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4738 · Cited by 180
“Prostacyclin has been shown to play a role in acute inflammation (22).”
BackgroundFabre, J.-E., Nguyen, M., Athirakul, K., Coggins, K., McNeish, J. D., Austin, S., Parise, L. K., FitzGerald, G. A., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10881 · Cited by 172
“Thrombosis was scored from 0 to 4 as proposed previously (18).”
BackgroundDoi, Y., Itoh, M., Yonemura, S., Ishihara, S., Takano, H., Noda, T., Tsukita, S., & Tsukita, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2315 · Cited by 173
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“Although none of the COXmetabolites overtly cause pain, PGI2 and PGE2 cause peripheral and central hyperalgesia when bound to IP, EP1, EP3 and EP4 receptors, respectively, by reducing the threshold of nociceptor sensory neurons to stimulation (34, 38, 62-70).”
BackgroundBadimon, L., Vilahur, G., Rocca, B., & Patrono, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab003 · Cited by 172
“IP-deleted mice showed an increased susceptibility to experimental thrombosis.(59) Concomitant IP and TP deletion in animal models confirmed that PGI2 is the prostanoid that physiologically counterbalances the pro-thrombotic effect of TXA2/ TP activation.”
BackgroundShinomiya, S., Naraba, H., Ueno, A., Utsunomiya, I., Maruyama, T., Ohuchida, S., Ushikubi, F., Yuki, K., Narumiya, S., Sugimoto, Y., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00586-x · Cited by 172
Self-citationEmerging Molecular Approaches to Pain Therapy
Williams, M., Kowaluk, E. A., & Arneric, S. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805034 · Cited by 172
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
Mubarak, K. K. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.07.015 · Cited by 165
Role of aspirin in primary prevention of cardiovascular disease
Patrono, C., & Baigent, C. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0225-y · Cited by 172
Kuwano, K., Hashino, A., Asaki, T., Hamamoto, T., Yamada, T., Okubo, K., & Kuwabara, K. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124248 · Cited by 164
“Studies on IP receptor-deficient mice have clarified the role of the PGI2-IP system, and we now know that IP receptor deficiency induces thrombus formation and reduces inflammatory and pain responses (Murata et al., 1997).”
BackgroundHennan, J. K., Huang, J., Barrett, T. D., Driscoll, E. M., Willens, D. E., Park, A. M., Crofford, L. J., & Lucchesi, B. R. (2001) · Circulation · doi:10.1161/hc3301.092790 · Cited by 163
Cardiovascular effects of cyclooxygenase‐2 inhibitors: a mechanistic and clinical perspective
Patrono, C. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13048 · Cited by 162
Prostaglandins and the initiation of blastocyst implantation and decidualization
Kennedy, T. G., Gillio-Meina, C., & Phang, S. H. (2007) · Reproduction · doi:10.1530/rep-07-0328 · Cited by 162
“In support of this conclusion is the fact that Ptgir null female mice are fertile (Murata et al. 1997).”
Prostanoid receptor antagonists: development strategies and therapeutic applications
Jones, R., Giembycz, M. A., & Woodward, D. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00317.x · Cited by 172
Zhang, H., Li, S., Doan, T., Rieke, F., Detwiler, P. B., Frederick, J. M., & Baehr, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701681104 · Cited by 159
Xu, D., Rowland, S. E., Clark, P., Giroux, A., Côté, B., Guiral, S., Salem, M., Ducharme, Y., Friesen, R. W., Méthot, N., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138776 · Cited by 159
“Unlike inflammatory pain, in which PGI2 may also play an important role (Murata et al., 1997; Pulichino et al., 2006), pyresis is mediated primarily by PGE2 (Ushikubi et al.”
BackgroundSignaling through Gi Family Members in Platelets
Yang, J., Wu, J., Jiang, H., Mortensen, R. M., Austin, S. C., Manning, D. R., Woulfe, D. S., & Brass, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208519200 · Cited by 155
Minireview: A Novel Pathway of Prostacyclin Signaling—Hanging Out with Nuclear Receptors
Lim, H. J., & Dey, S. K. (2002) · Endocrinology · doi:10.1210/en.2002-220159 · Cited by 170
“Although the anticoagulating activity of PGI2 seems to be mediated primarily by IP (21), its effects on vasculature may be shared between IP and PPAR .”
Prostacyclin: An Inflammatory Paradox
Stitham, J., Midgett, C. R., Martin, K. A., & Hwa, J. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00024 · Cited by 170
“…among those drugs with greater volume of evidence in terms of exposure in patient-years (Chen et al., 2008), presumably as a by-product of the discriminating suppression of COX-2-derived PGI 2, which has been shown to be cardioprotective (Murata et al., 1997; Cheng et al., 2002; Egan et al., 2004).”
Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia
Takayama, K., Yuhki, K., Ono, K., Fujino, T., Hara, A., Yamada, T., Kuriyama, S., Karibe, H., Okada, Y., Takahata, O., et al. (2005) · Nature Medicine · doi:10.1038/nm1231 · Cited by 152
Self-citationMuscle injuries and repair: the role of prostaglandins and inflammation.
Prisk, V. R., & Huard, J. (2003) · PubMed · doi:10.14670/hh-18.1243 · Cited by 172
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Kim, J. I., Lakshmikanthan, V., Frilot, N., & Daaka, Y. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0511 · Cited by 151
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
Francois, H., Athirakul, K., Howell, D. N., Dash, R., Mao, L., Kim, H., Rockman, H. A., FitzGerald, G. A., Koller, B. H., & Coffman, T. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.005 · Cited by 151
“However, previous studies in mouse models have suggested that prostacyclin may have little effect on resting blood pressure (Cheng et al., 2002; Murata et al., 1997; Watanabe et al., 2005; Xiao et al., 2001) or may actually promote hypertension caused by renal artery stenosis (Fujino et al.”
BackgroundResultIkemoto, A., Ohishi, M., Sato, Y., Hata, N., Misawa, Y., Fujii, Y., & Okuyama, H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32220-3 · Cited by 150
Endogenous Mechanisms of Inhibition of Platelet Function
JIN, R. C., VOETSCH, B., & LOSCALZO, J. (2005) · Microcirculation · doi:10.1080/10739680590925493 · Cited by 145
“Murata and colleagues studied the homeostatic role of PGI2 in response to thrombotic events (41).”
BackgroundHirata, T., & Narumiya, S. (2011) · Chemical Reviews · doi:10.1021/cr200010h · Cited by 148
Self-citationReese, J., Paria, B. C., Brown, N., Zhao, X., Morrow, J. D., & Dey, S. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9759 · Cited by 147
Prostacyclin Receptor-dependent Modulation of Pulmonary Vascular Remodeling
Hoshikawa, Y., Voelkel, N. F., Gesell, T., MOORE, M. D., Morris, K. G., Alger, L., Narumiya, S., & Geraci, M. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2010150 · Cited by 145
Self-citationWang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2008) · Circulation · doi:10.1161/circulationaha.107.731398 · Cited by 142
Arachidonic acid cascade in endothelial pathobiology
Bogatcheva, N. V., Sergeeva, M. G., Dudek, S. M., & Verin, A. D. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.01.007 · Cited by 141
The pathophysiology of cancer-induced bone pain: current understanding
Urch, C. (2004) · Palliative Medicine · doi:10.1191/0269216304pm887ra · Cited by 144
Prostacyclin: A Vascular Mediator
Vane, J. R., & Corin, R. E. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(03)00385-x · Cited by 138
Cha, Y. I., Solnica-Krezel, L., & DuBois, R. N. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.013 · Cited by 133
“Although disruption of the mouse IP gene did not appear to cause any abnormality of the ductus (Murata et al., 1997), mice without EP4 receptors died within 3 days after birth, due to marked pulmonary congestion and heart failure (Nguyen et al.”
InfluentialAmerican College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Hirsh, J., Guyatt, G. H., Albers, G. W., & Harrington, R. A. (2015) · Cited by 137
Molecular signaling in uterine receptivity for implantation
Paria, B. C., Lim, H. J., Das, S. K., Reese, J., & Dey, S. K. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0153 · Cited by 157
Cyclooxygenase inhibition and thrombogenicity
Catella-Lawson, F., & Crofford, L. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00683-5 · Cited by 136
Nonsteroidal Anti-Inflammatory Drugs and the Heart
Patrono, C., & Baigent, C. (2014) · Circulation · doi:10.1161/circulationaha.113.004480 · Cited by 139
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors
Côté, B., Boulet, L., Brideau, C., Claveau, D., Ethier, D., Frenette, R., Gagnon, M., Giroux, A., Guay, J., Guiral, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.033 · Cited by 130
What Can Proteomics Tell Us About Platelets?
Burkhart, J. M., Gambaryan, S. P., Watson, S. P., Jurk, K., Walter, U., Sickmann, A., Heemskerk, J. W. M., & Zahedi, R. P. (2014) · Circulation Research · doi:10.1161/circresaha.114.301598 · Cited by 140
Olah, Z., Karai, L., & Iadarola, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101607200 · Cited by 127
Augmentation of allergic inflammation in prostanoid IP receptor deficient mice
Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S., & Nagai, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704872 · Cited by 132
Self-citationModeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and Antagonists
Kim, S., Gao, Z., Rompaey, P. V., Gross, A. S., Chen, A., Calenbergh, S. V., & Jacobson, K. A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300431 · Cited by 131
FitzGerald, G. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02234-8 · Cited by 136
Lawler, O. A., Miggin, S. M., & Kinsella, B. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104434200 · Cited by 125
Arehart, E. J., Stitham, J., Asselbergs, F. W., Douville, K. L., MacKenzie, T. A., Fetalvero, K. M., Gleim, S., Kasza, Z., Rao, Y., Martel, L., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.165936 · Cited by 124
Prostanoids in nociception and pain
Zeilhofer, H. U. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.037 · Cited by 136
“Consistent with the existence of only a single IP receptor, the pronociceptive effects of PGI2 were completely absent in IP / mice tested in the mouse writhing test [27] or after subcutaneous injection [26].”
BackgroundResultInfluentialNakao, K., Murase, A., Ohshiro, H., Okumura, T., Taniguchi, K., Murata, Y., Masuda, M., Kato, T., Okumura, Y., & Takada, J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122010 · Cited by 122
“Studies performed either in mutant mice lacking the individual PG receptors (Murata et al., 1997; Minami et al., 2001; Stock et al., 2001) or with synthetic EP receptor agonist/antagonist (Minami et al., 1994; Nakayama et al., 2002) have not yet provided a coherent picture of which EP receptors are…”
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program
Weir, M. R., SPERLING, R. S., Reicin, A. S., & Gertz, B. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00398-3 · Cited by 132
Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi-Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 113
Self-citationBoulet, L., Ouellet, M., Bateman, K. P., Ethier, D., Percival, M. D., Riendeau, D., Mancini, J. A., & Méthot, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400443200 · Cited by 120
Prostacyclin in Vascular Diseases - Recent Insights and Future Perspectives -
Kawabe, J.-I., Ushikubi, F., & Hasebe, N. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0195 · Cited by 119
Self-citationEicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2013) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 113
Alfranca, A., Iñiguez, M. A., Fresno, M., & Redondo, J. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.020 · Cited by 118
“In contrast to PGI2, endothelial-derived NO is involved in the vasodilator response under homeostatic conditions; mice deficient in eNOS exhibit basal arterial hypertension [77], whereas IP-deficient mice do not show a spontaneous rise in arterial tension [78].”
Prostanoids and inflammatory pain
Chen, L., Yang, G., & Großer, T. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.08.006 · Cited by 118
Prostanoids as Regulators of Innate and Adaptive Immunity
Hirata, T., & Narumiya, S. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00005-3 · Cited by 126
Self-citationCardioprotective prostacyclin signaling in vascular smooth muscle
Fetalvero, K. M., Martin, K. A., & Hwa, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.011 · Cited by 116
COX-2–Derived Prostacyclin Modulates Vascular Remodeling
Rudic, R. D., Brinster, D. R., Cheng, Y., Fries, S., Song, W., Austin, S. C., Coffman, T. M., & FitzGerald, G. A. (2005) · Circulation Research · doi:10.1161/01.res.0000170888.11669.28 · Cited by 116
Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents
Marnett, L. J., & Kalgutkar, A. S. S. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80124-5 · Cited by 116
Prostaglandin Receptor Signaling in Disease
Matsuoka, T., & Narumiya, S. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.182 · Cited by 115
“Murata et al.[8] employed carrageenan-induced paw swelling as a model for acute inflammation.”
BackgroundSelf-citationYokoyama, C., Yabuki, T., Shimonishi, M., Wada, M., Hatae, T., Ohkawara, S., Takeda, J., Kinoshita, T., Okabe, M., & Tanabe, T. (2002) · Circulation · doi:10.1161/01.cir.0000034733.93020.bc · Cited by 123
Mogil, J. S., & Grisel, J. E. (1998) · Pain · doi:10.1016/s0304-3959(98)00093-1 · Cited by 120
“) injection of dilute acetic acid was observed in KOs (Murata et al., 1997).”
BackgroundInfluentialRole of direct cytotoxic effects of NSAIDs in the induction of gastric lesions
Tomisato, W., Tsutsumi, S., Hoshino, T., Hwang, H.-J., Mio, M., Tsuchiya, T., & Mizushima, T. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.020 · Cited by 126
Fujino, T., Nakagawa, N., Yuhki, K., Hara, A., Yamada, T., Takayama, K., Kuriyama, S., Hosoki, Y., Takahata, O., Taniguchi, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21382 · Cited by 114
Self-citationPulichino, A.-M., Rowland, S., Wu, T. Y.-H., Clark, P., Xu, D., Mathieu, M., Riendeau, D., & Audoly, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110387 · Cited by 131
“Our results further confirm, at the pharmacological level, the contribution of PGI2-mediated processes in acute inflammatory reactions previously described in IP / mice and with other IP antagonists (Murata et al., 1997; Keitz et al., 2004; Bley et al., 2006).”
BackgroundResultMatsuoka, Y., Furuyashiki, T., Bito, H., Ushikubi, F., Tanaka, Y., Kobayashi, T., Muro, S., Satoh, N., Kayahara, T., Higashi, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633341100 · Cited by 110
Self-citationAdventures in vascular biology: a tale of two mediators
Moncada, S. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1775 · Cited by 113
“Reprinted, with permission, from Needleman et al. (1976). Adventures in vascular biology S.”
BackgroundThe Isoprostanes: A Perspective
Rokach, J., Khanapure, S. P., Hwang, S.-W., Adiyaman, M., Lawson, J. A., & FitzGerald, G. A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00183-4 · Cited by 110
Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis
Vila, L. (2004) · Medicinal Research Reviews · doi:10.1002/med.10065 · Cited by 113
REVIEW ARTICLES: Platelet G protein-coupled receptors in hemostasis and thrombosis
Woulfe, D. S. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01338.x · Cited by 106
Pathophysiology and treatment of pain in joint disease☆
Schaible, H., Schmelz, M., & Tegeder, I. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.011 · Cited by 120
Hara, A., Yuhki, K., Fujino, T., Yamada, T., Takayama, K., Kuriyama, S., Takahata, O., Karibe, H., Okada, Y., Xiao, C.-Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.527077 · Cited by 103
Self-citationPPARδ Functions as a Prostacyclin Receptor in Blastocyst Implantation
Lim, H. J., & Dey, S. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00243-5 · Cited by 108
Belmonte, N., Phillips, B. W., Massiera, F., Villageois, P., Wdziekonski, B., Saint-Marc, P., Nichols, J., Aubert, J., Saeki, K., Yuo, A., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0721 · Cited by 98
Self-citationProstaglandin receptors: their role in regulating renal function
Breyer, M. D., & BREYER, R. M. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200001000-00005 · Cited by 101
Characterization of prostanoid receptor‐evoked responses in rat sensory neurones
Smith, J. A. M., Amagasu, S. M., Eglen, R. M., Hunter, J. C., & Bley, K. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701853 · Cited by 101
“The most convincing evidence for a role of IP receptors in in¯ammatory hyperalgesia has been obtained from recent studies with transgenic mice lacking the IP receptor (Murata et al., 1997).”
BackgroundCardiovascular complications of non-steroidal anti-inflammatory drugs.
Fosslien, E. (2005) · PubMed · Cited by 122
Role of Prostaglandin I2 in Airway Remodeling Induced by Repeated Allergen Challenge in Mice
Nagao, K., Tanaka, H., Komai, M., Masuda, T., Narumiya, S., & Nagai, H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0035oc · Cited by 99
Self-citationCross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells
Osanai, T., Fujita, N., Fujiwara, N., Nakano, T., Takahashi, K., Guan, W., & Okumura, K. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.1.h233 · Cited by 99
“ENDOTHELIAL CELLS in normal blood vessels secrete prostacyclin and nitric oxide (NO), and these compounds synergistically contribute to vessel homeostasis by inhibiting vascular smooth muscle tone (31, 35) and growth (12, 18), platelet aggregation (16), leukocyte adhesion to endothelium (34, 35, 37), and susceptibilit…”
BackgroundBley, K. R., Bhattacharya, A., Daniels, D. V., Gever, J. R., Jahangir, A. M., O-Yang, C., Smith, S., Srinivasan, D. K., Ford, A. P. D. W., & Jett, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706554 · Cited by 99
“…with data derived from IP receptor knockout mice, which have suggested that PGI2 working through the IP receptor – and not PGE2 – is the major mediator of acetic acidinduced visceral nociception (Murata et al., 1997; Ueno et al., 2001) and carrageenan-induced paw edema (Ueno et al., 2000).”
BackgroundImportance of quantitative genetic variations in the etiology of hypertension
Smithies, O., Kim, H., Takahashi, N., & Edgell, M. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00411.x · Cited by 105
Clapp, L. H., & Gurung, R. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.007 · Cited by 101
“[53] Murata T, Ushikubi F, Matsuoka T, et al.”
BackgroundInfluentialAnalgesic strategies beyond the inhibition of cyclooxygenases
Zeilhofer, H. U., & Brune, K. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.007 · Cited by 110
Yuhki, K., Kojima, F., Kashiwagi, H., Kawabe, J.-I., Fujino, T., Narumiya, S., & Ushikubi, F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.004 · Cited by 106
Self-citationRegulation of renal function by prostaglandin E receptors
Breyer, M. D., Zhang, Y.-H., Guan, Y., Hao, C., Hébert, R., & BREYER, R. M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06718.x · Cited by 97
“In this regard, the availability of mice with targeted disruption of specific EP receptor genes should prove an invaluable resource for evaluating the function of specific EP receptor”
BackgroundOchi, T., Motoyama, Y., & Goto, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00051-0 · Cited by 102
Role of endothelial cells in bovine mammary gland health and disease
Ryman, V. E., Packiriswamy, N., & Sordillo, L. M. (2015) · Animal Health Research Reviews · doi:10.1017/s1466252315000158 · Cited by 100
“Activation of the PGI2 receptor, a G-protein-coupled receptor (GPCR), causes an increase in adenylyl cyclase-dependent cAMP and subsequent vasodilation as a result of protein kinase A activation (Murata et al., 1997).”
BackgroundVane, J. R. (2002) · Science · doi:10.1126/science.1071702 · Cited by 93
Cardiovascular hazard and non-steroidal anti-inflammatory drugs
Wong, D., Wang, M., Cheng, Y., & FitzGerald, G. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.02.001 · Cited by 102
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.